Show simple item record

dc.contributor.authorGroeneveld, Geert H
dc.contributor.authorWijn, Dirk H
dc.contributor.authorVollaard, Albert M
dc.date.accessioned2019-10-11T12:11:42Z
dc.date.available2019-10-11T12:11:42Z
dc.date.issued2019-06-17
dc.identifier.issn1537-6591
dc.identifier.pmid31210266
dc.identifier.doi10.1093/cid/ciz512
dc.identifier.urihttp://hdl.handle.net/10029/623322
dc.language.isoenen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectimmune checkpoint inhibitorsen_US
dc.subjectimmune related adverse eventsen_US
dc.subjectimmunogenicityen_US
dc.subjectinfluenza vaccinationen_US
dc.subjectvaccine coverageen_US
dc.titleImmune related adverse events in cancer patients receiving influenza vaccination and immune checkpoint inhibitors.en_US
dc.typeArticleen_US
dc.identifier.journalClin Infect Dis 2019; advance online publication (ahead of print)en_US
dc.source.journaltitleClinical infectious diseases : an official publication of the Infectious Diseases Society of America


This item appears in the following Collection(s)

Show simple item record